Systemic Administration of miRNA Mimics by Liposomal Delivery System in Animal Model of Colorectal Carcinoma
- 15 December 2016
- journal article
- Published by Institute of Physiology of the Czech Academy of Sciences in Physiological Research
- Vol. 65 (Suppl 4), S481-S488
- https://doi.org/10.33549/physiolres.933546
Abstract
MiRNAs are important regulators of gene expression and changes in their levels are linked with various pathological states, including solid tumors. MiR-215 has been identified as a tumor suppressor in colorectal cancer (CRC). Following our previous in vitro and in vivo experiments, the aim of this project was to study the possibility of increasing the levels of miR-215 in tumor cells by systemic administration of miRNA mimics in liposomal delivery system in vivo. By subcutaneous xenotransplantation of human cancer cells to NSG mice, CRC model was established. The treatment [miR-215 mimics in liposomes (20 and 40 μg/mouse), control oligonucleotide in liposomes, or saline] was administered repeatedly by i.v. injection via tail-vein. Animals were sacrificed, tumor were dissected and measured by a caliper. Expression of miR-215 in tumors, lungs and liver was quantified by RT-PCR. There was no significant differences in tumor volume and miR-215 expression between all three treatment groups. Therefore, the decrease in tumor volume was not achieved. By comparing the levels of miR-215 in lungs, liver and tumors after the treatment, we suggest that the liposomes are accumulated in the lungs and do not concentrate sufficiently in the tumor site to exert significant tumor-suppressive effect.Keywords
This publication has 24 references indexed in Scilit:
- The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomasEmerging Therapeutic Targets, 2015
- A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation.Nucleic Acids Research, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple MyelomaOncotarget, 2013
- DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myelomaOncotarget, 2012
- Identification and functional screening of microRNAs highly deregulated in colorectal cancerJournal of Cellular and Molecular Medicine, 2012
- Let-7a Is a Direct EWS-FLI-1 Target Implicated in Ewing's Sarcoma DevelopmentPLOS ONE, 2011
- A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancerEuropean Journal of Cancer, 2011
- p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle ArrestCancer Research, 2008
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006